Articles related to DEVICE/DRUG APPROVALS

Explore the new era of Parkinson’s disease treatment with the Cala kIQ System, a wearable, FDA-approved device designed to control action tremors by emulating the principles of deep brain stimulation.

Explore how the newly FDA-cleared iLet Bionic Pancreas, integrating the iLet ACE Pump and the iLet Dosing Decision Software, could reshape the landscape of type 1 diabetes management through its adaptive and autonomous insulin dosing capabilities.

Accelerate your understanding of thrombotic disease treatment developments; delve into the Fast Track designation of milvexian, a promising oral factor XIa inhibitor.

Explore how the recent FDA approval of Epkinly is poised to transform the therapeutic landscape for adults with relapsed or refractory DLBCL and high-grade B-cell lymphoma.

As the optometry field advances, newer, more innovative medications are being introduced for the management of dry eye disease and Demodex blepharitis. These developments pave the way for more personalized and successful patient care.

Opvee Reverses Remifentail-induced Respiratory Depression Within 5 Minutes As the opioid crisis continues to evolve, so too does your arsenal of interventions. The FDA’s recent approval of Opvee, a nalmefene-based nasal spray, introduces a new tool for physicians in the fight against opioid overdose.